Robert Hariri

Celgene Corp.

Image: Robert  Hariri

Dr. Robert J. Hariri is considered a visionary serial entrepreneur in biomedicine. The chairman and former CEO of Celgene Cellular Therapeutics, one of the world's largest human cellular therapeutics companies, Hariri has pioneered the use of stem cells and biomaterials to treat a range of life-threatening diseases. Dr. Hariri has more than 100 issued and pending patents, and has authored more than 100 published chapters, articles and abstracts. He is recognized for his discovery of pluripotent stem cells from the placenta, and is a member of the team that discovered tumor necrosis factor. Dr. Hariri was recipient of the Thomas Alva Edison Award in 2007 and 2011. He serves on numerous boards of directors, including MYOS Corp. and Provista Diagnostics Inc. He is a member of the board of visitors of the Columbia University School of Engineering and Applied Sciences and the Science and Technology Council of the College of Physicians and Surgeons, as well as a member of the scientific advisory board for the Archon XPRIZE for Genomics. Dr. Hariri is also a trustee of the J. Craig Venter Institute and the Liberty Science Center, and has been appointed commissioner of cancer research by New Jersey Governor Chris Christie. Dr. Hariri received his undergraduate training at Columbia College and Columbia University School of Engineering and Applied Sciences, and was awarded his M.D. and Ph.D. degrees from Cornell University Medical College. Dr. Hariri received his surgical training at the New York Hospital-Cornell Medical Center, and directed the Aitken Neurosurgery Laboratory and the Center for Trauma Research.

Due to permission requirements, not all quotes are shown.